Royal Bank of Canada’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-43,856
| Closed | -$179K | – | 8194 |
|
|
2022
Q1 | $179K | Sell |
43,856
-25,590
| -37% | -$92.8K | ﹤0.01% | 5183 |
|
|
2021
Q4 | $248K | Buy |
69,446
+25,913
| +60% | +$90.6K | ﹤0.01% | 5120 |
|
|
2021
Q3 | $159K | Buy |
43,533
+2,754
| +7% | +$11.1K | ﹤0.01% | 5371 |
|
|
2021
Q2 | $178K | Buy |
40,779
+266
| +0.7% | +$1.08K | ﹤0.01% | 5176 |
|
|
2021
Q1 | $166K | Buy |
40,513
+3,210
| +9% | +$13.9K | ﹤0.01% | 5093 |
|
|
2020
Q4 | $149K | Buy |
37,303
+3,703
| +11% | +$12K | ﹤0.01% | 5077 |
|
|
2020
Q3 | $90K | Buy |
33,600
+19,187
| +133% | +$53.1K | ﹤0.01% | 5038 |
|
|
2020
Q2 | $40K | Sell |
14,413
-22,837
| -61% | -$63.7K | ﹤0.01% | 5324 |
|
|
2020
Q1 | $88K | Buy |
37,250
+24,201
| +185% | +$82.3K | ﹤0.01% | 4854 |
|
|
2019
Q4 | $61K | Sell |
13,049
-1,201
| -8% | -$4.92K | ﹤0.01% | 5357 |
|
|
2019
Q3 | $47K | Hold |
14,250
| – | – | ﹤0.01% | 5149 |
|
|
2019
Q2 | $47K | Sell |
14,250
-1,500
| -10% | -$4.34K | ﹤0.01% | 5316 |
|
|
2019
Q1 | $48K | Hold |
15,750
| – | – | ﹤0.01% | 5187 |
|
|
2018
Q4 | $43K | Sell |
15,750
-4,076
| -21% | -$13.4K | ﹤0.01% | 5179 |
|
|
2018
Q3 | $66K | Buy |
19,826
+5,944
| +43% | +$18.4K | ﹤0.01% | 5093 |
|
|
2018
Q2 | $36K | Buy |
13,882
+86
| +0.6% | +$214 | ﹤0.01% | 5298 |
|
|
2018
Q1 | $30K | Sell |
13,796
-2,776
| -17% | -$6.25K | ﹤0.01% | 5306 |
|
|
2017
Q4 | $33K | Sell |
16,572
-5,852
| -26% | -$12.7K | ﹤0.01% | 5370 |
|
|
2017
Q3 | $73K | Buy |
22,424
+12,674
| +130% | +$39.1K | ﹤0.01% | 5221 |
|
|
2017
Q2 | $32K | Sell |
9,750
-38
| -0.4% | -$108 | ﹤0.01% | 5335 |
|
|
2017
Q1 | $28K | Buy |
9,788
+38
| +0.4% | +$91 | ﹤0.01% | 5463 |
|
|
2016
Q4 | $23K | Sell |
9,750
-44
| -0.4% | -$84 | ﹤0.01% | 5701 |
|
|
2016
Q3 | $16K | Sell |
9,794
-556
| -5% | -$681 | ﹤0.01% | 5631 |
|
|
2016
Q2 | $10K | Hold |
10,350
| – | – | ﹤0.01% | 5749 |
|
|
2016
Q1 | $9K | Sell |
10,350
-20,073
| -66% | -$19.4K | ﹤0.01% | 5777 |
|
|
2015
Q4 | $36K | Buy |
30,423
+12,903
| +74% | +$18K | ﹤0.01% | 5476 |
|
|
2015
Q3 | $29K | Sell |
17,520
-874
| -5% | -$1.71K | ﹤0.01% | 5417 |
|
|
2015
Q2 | $39K | Buy |
18,394
+9,544
| +108% | +$23.1K | ﹤0.01% | 5370 |
|
|
2015
Q1 | $24K | Hold |
8,850
| – | – | ﹤0.01% | 5285 |
|
|
2014
Q4 | $23K | Buy |
8,850
+1,000
| +13% | +$2.25K | ﹤0.01% | 5367 |
|
|
2014
Q3 | $15K | Buy |
7,850
+3,600
| +85% | +$7.85K | ﹤0.01% | 5369 |
|
|
2014
Q2 | $11K | Hold |
4,250
| – | – | ﹤0.01% | 5384 |
|
|
2014
Q1 | $15K | Sell |
4,250
-1,000
| -19% | -$4.44K | ﹤0.01% | 5301 |
|
|
2013
Q4 | $23K | Sell |
5,250
-3,277
| -38% | -$13.4K | ﹤0.01% | 5208 |
|
|
2013
Q3 | $34K | Buy |
8,527
+3,277
| +62% | +$14.3K | ﹤0.01% | 4973 |
|
|
2013
Q2 | $22K | Buy |
+5,250
| New | +$20.3K | ﹤0.01% | 4997 |
|
Other funds holding ATRS
Royal Bank of Canada's ATRS Position: Q2 2022 in Review
Royal Bank of Canada sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 43,856 shares — an estimated $179K sold.
Royal Bank of Canada first reported a position in ATRS in Q2 2013 and held it in 36 quarters. The position peaked at $248K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Royal Bank of Canada reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Royal Bank of Canada sold 43,856 Antares Pharma, Inc. shares in Q2 2022, an estimated $179K.
- Royal Bank of Canada first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 36 quarters.
- Royal Bank of Canada's Antares Pharma, Inc. position peaked at $248K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.